港股異動丨萬國數據大跌超13%,Q4收入遜預期
萬國數據(9698.HK)盤中大跌超13%,至29.4港元。公司公佈,截至去年12月底止第四季度淨收入增加9.1%至26.9億元,不及預期;季度經調整EBITDA同比增長13.9%至12.98億元;季度純利41.75億元,2023年度同期虧損31億元,因期間終止經營業務產生利潤42.8億元,每股盈利2.81元,而期內持續經營業務的淨虧損為1.7億元。萬國數據2024年全年純利33.7億元,2023年度則虧損43億元,每股盈利2.29元,淨收入增加5.5%至約103億元,持續經營業務淨虧損降至7.7億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.